Search results
Best High cholesterol Doctors in Nevada
US News Health· 9 hours agoThere are 1000 doctors in Nevada that treat High cholesterol. Find the best for you: Ronny Jiji, MD, Alfred Danielian, MD, Anthony Dota III, MD, Phil Aldrich, MD, Leo Capobianco, DO.
90% of U.S. Adults Have This Syndrome That Leads to Heart Disease—and Have No Clue
Prevention via Yahoo News· 3 hours agoCKM syndrome, a cluster of conditions that may lead to heart disease, may affect 90% of U.S. adults....
Skin Tags Linked to Metabolic Syndrome in Children
Medscape· 5 days agoAcrochordons (skin tags) in children and adolescents may serve as a marker for metabolic diseases.
How to Lower Cholesterol Naturally
US News Health· 7 days agoIn patients who have coronary artery disease, peripheral artery disease or carotid artery disease, there is no question about the benefit of cholesterol-lowering medications such as statins.
New Analysis Finds Endoscopic Sleeve Gastroplasty More Cost Effective Than Lifestyle Modification...
PRWeb· 1 hour agoIn order to determine the total cost of ESG vs lifestyle modifications, Dr. Donnangelo and colleagues sought to analyze the cost in 860 real-world adults with class I-III obesity. From the analysis ...
Handbook on male sexual health released in Shanghai
China Daily· 16 hours agoCommon chronic diseases, such as hyperlipidemia, hypertension, high blood sugar, prostate diseases and infertility as well as mental health problems are usually their triggers ...
Another Benefit of Gout Treatment: CV Risk Reduction
Medscape· 5 days agoUrate, the culprit of gout, affects the vasculature in multiple ways that can raise cardiovascular risk (CV) in an individual with gout, and following...
StrokeClassifier: ischemic stroke etiology classification by ensemble consensus modeling using...
Nature· 4 days agoDetermining acute ischemic stroke (AIS) etiology is fundamental to secondary stroke prevention efforts but can be diagnostically challenging. We trained and validated an automated classification ...
Neurocrine shares new CAH treatment data at endocrinology congress By Investing.com
Investing.com· 7 days agoThe company presented baseline characteristics from the CAHtalyst™ Phase 3 trials of crinecerfont in...
Esperion Therapeutics (NASDAQ:ESPR) Cut to “Buy” at StockNews.com
ETF DAILY NEWS· 4 days agoA number of other research firms have also weighed in on ESPR. HC Wainwright restated a “buy” rating and issued a $16.00 target price on shares of Esperion Therapeutics in a report on Wednesday ...
